Lymphoma Working Party (LWP)
Study type:
Study number:
2020-R-13
Type of treatment:
Allogeneic
Diseases:
Short title:
Primary objective:
Key inclusion criteria:
Country:
Principal investigator:
Norbert Schmitz
EBMT Study coordinator:
Hervé Finel
Study coordinator email:
herve.finel@upmc.fr